Compare TALKW & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TALKW | SNN |
|---|---|---|
| Founded | 2012 | 1856 |
| Country | United States | United Kingdom |
| Employees | 598 | 16988 |
| Industry | Medical/Nursing Services | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 14.3B |
| IPO Year | N/A | N/A |
| Metric | TALKW | SNN |
|---|---|---|
| Price | $0.00 | $31.87 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.25 |
| AVG Volume (30 Days) | 68.2K | ★ 828.2K |
| Earning Date | 02-20-2025 | 03-16-2026 |
| Dividend Yield | N/A | ★ 2.30% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $181,291,000.00 | N/A |
| Revenue This Year | N/A | $8.58 |
| Revenue Next Year | N/A | $5.60 |
| P/E Ratio | ★ N/A | $64.97 |
| Revenue Growth | ★ 31.50 | N/A |
| 52 Week Low | $0.00 | $26.33 |
| 52 Week High | $0.15 | $38.79 |
| Indicator | TALKW | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 43.43 | 38.96 |
| Support Level | N/A | $29.27 |
| Resistance Level | $0.01 | $32.22 |
| Average True Range (ATR) | 0.00 | 0.60 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 95.00 | 10.88 |
Talkspace Inc is a virtual behavioral healthcare company offering its members convenient and affordable access to a fully-credentialed network of qualified providers across a wide and growing spectrum of care through virtual psychotherapy and psychiatry. It is a single destination for comprehensive mental health care, including therapy for individuals, couples, and teens, as well as psychiatric treatment and medication management (18+), and self-guided tools and resources. The company's customers include Health insurance plans from commercial and government institutions, and employee assistance programs, Direct-to-Enterprise, and Individual subscribers. The company operates as a single segment.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.